The response of fibroblasts to these signals changes with age, such that they are less capable of producing a mature scar upon loss of cardiac myocytes, and more likely to produce interstitial ...
CSPC Pharmaceutical Group Ltd. has obtained clearance from China’s National Medical Products Administration (NMPA) to conduct clinical trials in China of SYH-2059 tablets for interstitial lung disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback